Quarterly Result25 May 2026, 02:59 pm
Riddhi Siddhi Gluco Biols Approves ₹3 Dividend, Results
AI Summary
Riddhi Siddhi Gluco Biols Ltd's board approved audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board recommended a dividend of ₹3 per share (30%) and approved amendments to the Memorandum of Association, including changes to the Main Object Clause and shifting the registered office from Gujarat to Haryana, subject to shareholder and regulatory approvals. They also approved the appointment of M/s. J S Varma & Co as Internal Auditor for FY 2026-27.
Key Highlights
- Approved audited standalone and consolidated financial results for FY26.
- Recommended a dividend of ₹3 per share (30%) for FY26.
- Approved amendment to the Main Object Clause of the Memorandum of Association.
- Approved shifting of registered office from Gujarat to Haryana, subject to approvals.
- Appointed M/s. J S Varma & Co as Internal Auditor for FY 2026-27.
Price Impact
More from RIDDHI